Cushing's syndrome in pregnancy treated by ketoconazole: Case report and review of the literature

Gynecological Endocrinology

Volumn 13, Issue 3, 1999, Pages 175-182

  Berwaerts, J ^a,c   Verhelst, J ^a   Mahler, C ^a   Abs, R ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Cushing's; Estrogen; Fertility; Ketoconazole; Pregnancy; Teratogenicity

Indexed keywords

CABERGOLINE; KETOCONAZOLE;

ADULT; ARTICLE; CASE REPORT; CONGENITAL MALFORMATION; CONTRACEPTION; CUSHING SYNDROME; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPOPHYSIS; MALE; NEWBORN; PATIENT COMPLIANCE; PHYSICIAN; PREGNANCY; PRIORITY JOURNAL; SEXUAL DEVELOPMENT; SYMPTOM; TERATOGENICITY; TRANSSPHENOIDAL SURGERY; VAGINAL DELIVERY;

EID: 0033005616     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599909167552     Document Type: Article

References (49)

1. Nieman L, Cutler GB. Cushing's syndrome. In DeGroot LJ, ed. Endocrinology, 3rd edn. Philadelphia: WB Saunders Company, 1995:1741-69
2. Engelhardt D, Weber MM. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors. J Steroid Biochem Mol Biol 1994;49:261-7
3. Buescher MA, McClamrock HD, Adashi EY. Cushing syndrome in pregnancy. Obstet Gynecol 1992;79:130-7
4. Aron DC, Schnall AM, Sheeler LR. Cushing's syndrome and pregnancy. Am J Obstet Gynecol 1990; 162:244-52
5. Sheeler LR. Cushing's syndrome and pregnancy. Endocrinol Metab Clin N Am 1994;23:619-27
6. Chico A, Manzanares JM, Halperin I, et al. Cushing's disease and pregnancy: report of six cases. Eur J Obstet Gynecol Reprod Biol 1996;64:143-6
7. Guilhaume B, Sanson ML, Billaud L, et al. Cushing's syndrome and pregnancy: aetiologies and prognosis in twenty-two patients. Eur J Med 1992; 1:83-9
8. Prager D, Braunstein GD. Pituitary disorders during pregnancy. Endocrinol Metab Clin North Am 1995;24:1-14
9. Amado JA, Pesquera C, Gonzalez EM, et al. Successful treatment with ketoconazole of Cushing's syndrome in pregnancy. Postgrad Med J 1990;66: 221-3
10. Bevan JS, Gough MH, Gillmer MDG, et al. Cushing's syndrome in pregnancy: the timing of definitive treatment. Clin Endocrinol (Oxf.), 1987;27: 225-33
11. Pricolo VE, Monchik JM, Prinz RA, et al. Management of Cushing's syndrome secondary to adrenal adenoma during pregnancy. Surgery 1990;108: 1072-8
12. van der Spuy ZM, Jacobs HS. Management of endocrine disorders in pregnancy. Part II - pituitary, ovarian and adrenal disease. Postgrad Med J 1984;60:312-20
13. Hanson TJ, Ballonoff LB, Northcutt RC. Aminoglutethimide and pregnancy. J Am Med Assoc 1974; 230:963-4
14. Krieger DT, Amorosa L, Linick F. Cyproheptadine-induced remission of Cushing's disease. N Engl J Med 1975;293:893-6
15. Kasperlik-Zaluska A, Migdalska B, Hartwig W, et al. Two pregnancies in a woman with Cushing's syndrome treated with cyproheptadine. Case Report. Br J Obstet Gynaecol 1980;87:1171-3
16. Khir ASM, How J, Bewsher PD. Successful pregnancy after cyproheptadine treatment for Cushing's disease. Eur J Obstet Gynecol Reprod Biol 1982; 13:343-7
17. Gormley MJJ, Hadden DR, Kennedy TL, et al. Cushing's syndrome in pregnancy: treatment with metyrapone. Clin Endocrinol. (Oxf.) 1982;16: 283-93
18. Connell JMC, Cordiner J, Davies DL, et al. Pregnancy complicated by Cushing's syndrome: potential hazard of metyrapone therapy. Case report. Br J Obstet Gynaecol 1985;92:1192-5
19. Leiba S, Weinstein R, Shindel B, et al. The protracted effect of o,p′-DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo. Ann Endocrinol (Paris) 1989; 50:49-53
20. Aron DC, Schnall AM, Sheeler LR. Spontaneous resolution of Cushing's syndrome after pregnancy. Am J Obstet Gynecol 1990;162:472-4
21. Gerl H, Benecke R, Knappe G, et al. Pregnancy and partus in Cushing's disease treated with o,p′-DDD. Acta Endocrinol (Copenh.) 1992;126 (Suppl 4): 133
22. Close CF, Mann MC, Watts JF, et al. ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone. Clin Endocrinol (Oxf.) 1993;39:375-9
23. Wallace C, Toth EL, Lewanczuk RZ, et al. Pregnancy-induced Cushing's syndrome in multiple pregnancies. J Clin Endocrinol Metab 1996;81: 15-21
24. McKenna MJ, Linares M, Mellinger RC. Prolonged remission of Cushing's disease following bromocriptine therapy. Henry Ford Hosp Med J 1987;35:188-91
25. Lamberts SWJ, de Lange SA, Stefanko SZ. Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: differences in the regulation of hormone secretion. J Clin Endocrinol Metab 1982; 54:286-91
26. Boscaro M, Benato M, Mantero F. Effect of bromocriptine in pituitary-dependent Cushing's syndrome. Clin Endocrinol (Oxf.) 1983;19:485-91
27. Rains CP, Bryson HM, Fitton A. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyper-prolactinaemia and inhibition of lactation. Drugs 1995;49:255-79
28. Robert E, Musatti L, Piscitelli G, et al. Pregnancy outcome after treatment with the ergot derivative, cabergoline. Reprod Toxicol 1996;10:333-7
29. Feldman D. Ketoconazole and other imidazole derivatives as inhibitors of steroidogenesis. Endocrinol Rev 1986;7:409-20
30. Sonino N. The use of ketoconazole as an inhibitor of steroid production. N Engl J Med 1987;317: 812-8
31. Pont A, Goldman ES, Sugar AM, et al. Ketoconazole-induced increase in estradiol-testosterone ratio. Arch Intern Med 1985;145: 1429-31
32. Gal M, Barr I, Lior O, et al. Effect of ketoconazole on steroidogenic human granulosa-luteal cells in culture. Eur J Obstet Gynecol Reprod Biol 1991;39: 209-14
33. Gal M, Orly J, Barr I, et al. Low dose ketoconazole attenuates serum androgen levels in patients with polycystic ovary syndrome and inhibits ovarian steroidogenesis in vitro. Fertil Steril 1994;61: 823-32
34. DiMattina M, Maronian N, Ashby H, et al. Ketoconazole inhibits multiple steroidogenic enzymes involved in androgen biosynthesis in the human ovary. Fertil Steril 1988;49:62-5
35. 17,20-desmolase and aromatase. J Steroid Biochem Mol Biol 1991;38: 213-18
36. Ayub M, Stitch SR. Effects of ketoconazole on placental aromatase, 3β-hyroxysteroid dehydrogenase-isomerase and 17β-hydroxysteroid dehydrogenase. J Steroid Biochem 1986;25:981-4
37. Mason JI, Carr BR, Murry BA. Imidazole antimycotics: selective inhibitors of steroid aromatization and progesterone hydroxylation. Steroids 1987;50:179-89
38. Medda F, Puligheddu P, Parodo G, et al. Short term treatment with ketoconazole: effects on gonadal and adrenal steroidogenesis in women. Clin Exp Obstet Gynecol 1987;14:161-6
39. Wouters W, De Coster R, Goeminne N, et al. Aromatase inhibition by the antifungal ketoconazole. J Steroid Biochem 1988;30:387-9
40. Pepper G, Brenner SH, Gabrilove JL. Ketoconazole use in the treatment of ovarian hyperandrogenism. Fertil Steril 1990;54:438-44
41. Angeli A, Frairia R. Ketoconazole therapy in Cushing's disease. Lancet 1985;1:821
42. Sonino N, Boscaro M, Merola G, et al. Prolonged treatment of Cushing's disease by ketoconazole. J Clin Endocrinol Metab 1985;61:718-22
43. Loli P, Berselli ME, Tagliaferri M. Use of ketoconazole in the treatment of Cushing's syndrome. J Clin Endocrinol Metab 1986;63:1365-71
44. Sonino N, Boscaro M, Paoletta A, et al. Ketoconazole in Cushing's syndrome: experience in 34 patients. Clin Endocrinol (Oxf.) 1991;35: 347-52
45. Van Tyle JH. Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use. Pharmacotherapy 1984;4:343-73
46. Van Cauteren H, Lampo A, Vandenberghe J, et al. Safety aspects of oral antifungal agents. Br J Clin Pract 1990;71:47-9
47. Van Cauteren H, Lampo A, Vandenberghe J, et al. Toxicological profile and safety evaluation of antifungal azole derivatives. Mycoses 1989;32:60-6
48. McGregor JA, Pont A. Contraindication of ketoconazole in pregnancy. Am J Obstet Gynecol 1984; 150:793-4
49. Miller JW, Crapo L. The medical treatment of Cushing's syndrome. Endocr. Rev 1993;14:443-58